share_log

Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target

Moomoo 24/7 ·  Mar 21 12:52

Chardan Capital analyst Geulah Livshits reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $20 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment